U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07003776) titled 'Evaluation of Tumor Budding In Colorectal Adenocarcinoma' on May 26.
Brief Summary: Colorectal cancer (CRC) is among the most prevalent cancers globally, with approximately one to two million new cases diagnosed each year. This makes CRC the third most common cancer and the fourth leading cause of cancer-related deaths, with 700,000 deaths per year, exceeded only by lung, liver and stomach cancers. CRC accounts for about 10% of all cancer diagnoses worldwide (Sung et al., 2021; Masetti et al., 2022) .
CRC affects different races and ethnicities at various age groups in distinct ways. Among patients younger than 50 years old, the pro...